drugset / Trial / NCT04572516

Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis

NCT04572516 ↗

Phase 3 Completed 30 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

The present work aims to assess the effectiveness and safety of topical application of BTX - A compared with its intra turbinate injection in controlling the symptoms in non infectious chronic rhinosinusitis patients

Timeline

Start
2020-05-01
Primary completion
2021-06-15
Completion
2021-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulium Toxin Type A Unknown 20 iu Topical